Hui-Hsin Chang

Title: Innovations of Hui-Hsin Chang in Cryopreservation and Cell Production

Introduction

Hui-Hsin Chang is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of cell preservation and production, holding a total of 2 patents. His work focuses on developing methods and compositions that enhance the efficiency of cryopreserving mammalian cells and producing natural killer cells from pluripotent stem cells.

Latest Patents

Hui-Hsin Chang's latest patents include innovative compositions and methods for cryopreserving cells. One patent details a cryopreservation medium that comprises dimethyl sulfoxide (DMSO), disaccharide, human serum, and IL-7 and/or IL-15. This medium is designed to maintain the viability of mammalian cells during the freezing process. Another patent outlines a method for producing natural killer cells from induced pluripotent stem cells, which involves culturing pluripotent stem cells in a specific culture medium to generate CD56+/CD3− immune cells.

Career Highlights

Hui-Hsin Chang is currently associated with Takeda Pharmaceutical Company Limited, where he continues to advance research in cell preservation and immunology. His innovative approaches have the potential to significantly impact therapeutic applications in regenerative medicine and cancer treatment.

Collaborations

Hui-Hsin Chang has collaborated with notable colleagues, including Xi Shi and Jianxin Hu, to further enhance the research and development of his patented technologies.

Conclusion

Hui-Hsin Chang's contributions to the fields of cryopreservation and cell production exemplify the importance of innovation in medical research. His patents reflect a commitment to improving cell viability and therapeutic applications, paving the way for future advancements in the field.